tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jeffrey Hung, 86 are a HOLD (33.33%), 16 are a SELL (6.2%), 156 are a BUY (60.47%).
Analyst Jeffrey Hung, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 52.79% that have a potential upside of 26.14% achieved within 148 days.
Jeffrey Hung’s has documented 490 price targets and ratings displayed on 38 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CRNX, Crinetics Pharmaceuticals at 29-Sep-2025.
Analyst best performing recommendations are on RYTM (RHYTHM PHARMACEUTICALS).
The best stock recommendation documented was for RYTM (RHYTHM PHARMACEUTICALS) at 11/9/2022. The price target of $26 was fulfilled within 2 days with a profit of $3.75 (16.85%) receiving and performance score of 84.27.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$33
$12.94 (64.51%)
$34
13 days ago
(29-Sep-2025)
8/13 (61.54%)
$11.68 (54.78%)
113
Buy
$28
$7.94 (39.58%)
$30
18 days ago
(24-Sep-2025)
0/10 (0%)
$6.74 (31.70%)
Buy
$39
$18.94 (94.42%)
$35
1 months 1 days ago
(11-Sep-2025)
7/12 (58.33%)
$14.8 (61.16%)
671
Buy
$39
$18.94 (94.42%)
$32
1 months 3 days ago
(09-Sep-2025)
1/5 (20%)
$14.16 (57.00%)
349
Hold
$24
$3.94 (19.64%)
$23
2 months 5 days ago
(07-Aug-2025)
10/13 (76.92%)
$-0.4 (-1.64%)
157
Which stock is Jeffrey Hung is most bullish on?
Which stock is Jeffrey Hung is most reserved on?
What Year was the first public recommendation made by Jeffrey Hung?
